93rd Vifor Pharma Group Annual General Meeting

May 6, 2021

Regulatory News: At today’s 93rd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. In view of the ongoing COVID-19 pandemic and in...... Continue Reading >

Smiths Medical and Ivenix Partner to Revolutionize Infusion Management with First-Ever Comprehensive Suite of Infusion Solutions in US Healthcare Market

May 5, 2021

Smiths Medical, a global medical device leader, today announced it has formed an exclusive partnership with Ivenix, Inc. that positions the companies as the first in the U.S. to offer...... Continue Reading >

Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy

May 3, 2021

Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Applied Physiology in which Dr. Marina García-de-Acilu and colleagues at the Vall d’Hebron University Hospital in...... Continue Reading >

VFMCRP announces positive results of phase-III clinical trial of Velphoro® in China

April 30, 2021

Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced positive results from a phase-III study in China (PA-CL-CHINA-01), evaluating the efficacy of Velphoro® (PA21) compared to sevelamer...... Continue Reading >

Takeda Manufacturing Facilities in Japan and Ireland Recognized With Category Awards for 2021 Facilities of the Year

April 29, 2021

• Both Awards, Issued by the International Society for Pharmaceutical Engineering (ISPE), Underscore Takeda’s... Continue Reading >

Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel anti-infectives for the Middle East and North Africa region

April 29, 2021

Hikma Pharmaceuticals PLC (Hikma) and Melinta Therapeutics (Melinta) today announced they have entered into an exclusive licensing agreement for Vabomere® (meropenem and vaborbactam)...... Continue Reading >

Vifor Pharma and Angion announce completion of enrollment in phase-II study of ANG-3777 for cardiac-surgery associated acute kidney injury

April 29, 2021

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210428005922/en/ Vifor Pharma and Angion Biomedica Corp. (NASDAQ: ANGN), today announced completion...... Continue Reading >

COVID-19: opening of 8 additional vaccination centres (Ministry of Health)

April 28, 2021

TAP) - Eight additional COVID-19 vaccination centres have been opened recently, the Ministry of Health announced Tuesday. This takes the overall number of centres to 47 in different...... Continue Reading >

First patient enrolled in CARE-HK in HF to evaluate role of Veltassa® (patiromer) in enabling RAASi treatment

April 28, 2021

• CARE-HK in heart failure (HF) is the first global registry of around 5,000 patients with chronic HF who have or... Continue Reading >

Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer

April 28, 2021

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the...... Continue Reading >